nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—Lethargy—Prednisone—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Hydrocodone—Dizziness—Pentoxifylline—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Hydrocodone—Malnutrition—Lisinopril—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Hydrocodone—Fatigue—Captopril—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Hydrocodone—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Hydrocodone—Myalgia—Leflunomide—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Hydrocodone—Arthralgia—Leflunomide—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Hydrocodone—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Hydrocodone—Anxiety—Leflunomide—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Hydrocodone—Osteoarthritis—Prednisone—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Hydrocodone—Constipation—Captopril—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Hydrocodone—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Hydrocodone—Skin disorder—Azathioprine—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Hydrocodone—Affect lability—Prednisone—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Hydrocodone—Dry mouth—Leflunomide—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Hydrocodone—Cough—Mycophenolic acid—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Hydrocodone—Back pain—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Hydrocodone—Vomiting—Pentoxifylline—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Hydrocodone—Convulsion—Mycophenolic acid—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Hydrocodone—Muscle spasms—Lisinopril—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Hydrocodone—Rash—Pentoxifylline—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Hydrocodone—Dermatitis—Pentoxifylline—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Hydrocodone—Headache—Pentoxifylline—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Hydrocodone—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Hydrocodone—Myalgia—Mycophenolic acid—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Captopril—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Hydrocodone—Anxiety—Mycophenolic acid—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Hydrocodone—Asthenia—Mometasone—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Hydrocodone—Hypotension—Azathioprine—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Hydrocodone—Tremor—Lisinopril—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Hydrocodone—Mood swings—Prednisone—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Hydrocodone—Nervous system disorder—Leflunomide—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Hydrocodone—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Hydrocodone—Pruritus—Mometasone—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Hydrocodone—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Hydrocodone—Skin disorder—Leflunomide—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Hydrocodone—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Hydrocodone—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Hydrocodone—Abdominal pain—Captopril—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Hydrocodone—Body temperature increased—Captopril—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Hydrocodone—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Hydrocodone—Nausea—Pentoxifylline—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Hydrocodone—Hypokalaemia—Prednisone—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Hydrocodone—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Hydrocodone—Hypotension—Leflunomide—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Hydrocodone—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Hydrocodone—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Hydrocodone—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Hydrocodone—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Hydrocodone—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Hydrocodone—Cough—Lisinopril—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Hydrocodone—Insomnia—Leflunomide—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Hydrocodone—Paraesthesia—Leflunomide—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Hydrocodone—Arthralgia—Lisinopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Hydrocodone—Myalgia—Lisinopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Hydrocodone—Anxiety—Lisinopril—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Hydrocodone—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Hydrocodone—Dyspnoea—Leflunomide—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Hydrocodone—Hypotension—Mycophenolic acid—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Hydrocodone—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Hydrocodone—Lethargy—Methotrexate—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Hydrocodone—Vomiting—Mometasone—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Hydrocodone—Dry mouth—Lisinopril—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Hydrocodone—Rash—Mometasone—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Hydrocodone—Asthenia—Captopril—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Hydrocodone—Dermatitis—Mometasone—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Hydrocodone—Osteoarthritis—Methotrexate—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Hydrocodone—Headache—Mometasone—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Hydrocodone—Tremor—Mycophenolate mofetil—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Hydrocodone—Insomnia—Mycophenolic acid—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Hydrocodone—Fatigue—Leflunomide—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Hydrocodone—Pruritus—Captopril—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Hydrocodone—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Hydrocodone—Constipation—Leflunomide—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Hydrocodone—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Hydrocodone—Somnolence—Mycophenolic acid—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Hydrocodone—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Hydrocodone—Body temperature increased—Azathioprine—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Hydrocodone—Abdominal pain—Azathioprine—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Hydrocodone—Skin disorder—Lisinopril—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Hydrocodone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.002	0.002	CcSEcCtD
Hydrocodone—Fatigue—Mycophenolic acid—systemic scleroderma	0.002	0.002	CcSEcCtD
Hydrocodone—Mood swings—Methotrexate—systemic scleroderma	0.002	0.002	CcSEcCtD
Hydrocodone—Nausea—Mometasone—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Hydrocodone—Constipation—Mycophenolic acid—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Hydrocodone—Cough—Mycophenolate mofetil—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Hydrocodone—Hypotension—Lisinopril—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Hydrocodone—Dizziness—Captopril—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Hydrocodone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Hydrocodone—Abdominal pain—Leflunomide—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Hydrocodone—Body temperature increased—Leflunomide—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Hydrocodone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Hydrocodone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Hydrocodone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Hydrocodone—Hypersensitivity—Azathioprine—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Hydrocodone—Insomnia—Lisinopril—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Hydrocodone—Paraesthesia—Lisinopril—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Hydrocodone—Vomiting—Captopril—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Hydrocodone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Hydrocodone—Dyspnoea—Lisinopril—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Hydrocodone—Rash—Captopril—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Hydrocodone—Dermatitis—Captopril—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Hydrocodone—Somnolence—Lisinopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Hydrocodone—Headache—Captopril—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Hydrocodone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Hydrocodone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Hydrocodone—Fatigue—Lisinopril—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Hydrocodone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Hydrocodone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Hydrocodone—Hypersensitivity—Leflunomide—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Hydrocodone—Constipation—Lisinopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Hydrocodone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Hydrocodone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Hydrocodone—Nausea—Captopril—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Hydrocodone—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Hydrocodone—Asthenia—Leflunomide—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Hydrocodone—Pruritus—Leflunomide—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Hydrocodone—Connective tissue disorder—Prednisone—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Hydrocodone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Hydrocodone—Dizziness—Azathioprine—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Hydrocodone—Asthenia—Mycophenolic acid—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Hydrocodone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Hydrocodone—Abdominal pain—Lisinopril—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Hydrocodone—Body temperature increased—Lisinopril—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Hydrocodone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Hydrocodone—Pruritus—Mycophenolic acid—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Hydrocodone—Vomiting—Azathioprine—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Hydrocodone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Hydrocodone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Hydrocodone—Drowsiness—Methotrexate—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Hydrocodone—Rash—Azathioprine—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Hydrocodone—Dermatitis—Azathioprine—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Hydrocodone—Headache—Azathioprine—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Hydrocodone—Dizziness—Leflunomide—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Hydrocodone—Angiopathy—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Hydrocodone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Hydrocodone—Vomiting—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Hydrocodone—Hypersensitivity—Lisinopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Hydrocodone—Dizziness—Mycophenolic acid—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Hydrocodone—Rash—Leflunomide—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Hydrocodone—Dermatitis—Leflunomide—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Hydrocodone—Mental disorder—Prednisone—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Hydrocodone—Nausea—Azathioprine—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Hydrocodone—Headache—Leflunomide—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Hydrocodone—Malnutrition—Prednisone—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Hydrocodone—Agranulocytosis—Methotrexate—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Hydrocodone—Asthenia—Lisinopril—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Hydrocodone—Pruritus—Lisinopril—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Hydrocodone—Vomiting—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Hydrocodone—Rash—Mycophenolic acid—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Hydrocodone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Hydrocodone—Headache—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Hydrocodone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Hydrocodone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Hydrocodone—Nausea—Leflunomide—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Hydrocodone—Dizziness—Lisinopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Hydrocodone—Nausea—Mycophenolic acid—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Hydrocodone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Hydrocodone—Vomiting—Lisinopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Hydrocodone—Angiopathy—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Hydrocodone—Rash—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Hydrocodone—Convulsion—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Hydrocodone—Dermatitis—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Hydrocodone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Hydrocodone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Hydrocodone—Headache—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Hydrocodone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Hydrocodone—Arthralgia—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Hydrocodone—Myalgia—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Hydrocodone—Anxiety—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Hydrocodone—Mental disorder—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Hydrocodone—Malnutrition—Methotrexate—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Hydrocodone—Nausea—Lisinopril—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Hydrocodone—Back pain—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Hydrocodone—Nervous system disorder—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Hydrocodone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Hydrocodone—Skin disorder—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hydrocodone—Hyperhidrosis—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hydrocodone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Hydrocodone—Rash—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Hydrocodone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Hydrocodone—Headache—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Hydrocodone—Insomnia—Prednisone—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Hydrocodone—Paraesthesia—Prednisone—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Hydrocodone—Cough—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Hydrocodone—Convulsion—Methotrexate—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Hydrocodone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Hydrocodone—Arthralgia—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hydrocodone—Myalgia—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Hydrocodone—Fatigue—Prednisone—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Hydrocodone—Constipation—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Hydrocodone—Nervous system disorder—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Hydrocodone—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Hydrocodone—Skin disorder—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Hydrocodone—Hyperhidrosis—Methotrexate—systemic scleroderma	0.001	0.001	CcSEcCtD
Hydrocodone—Abdominal pain—Prednisone—systemic scleroderma	0.000979	0.000979	CcSEcCtD
Hydrocodone—Body temperature increased—Prednisone—systemic scleroderma	0.000979	0.000979	CcSEcCtD
Hydrocodone—Hypotension—Methotrexate—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Hydrocodone—Insomnia—Methotrexate—systemic scleroderma	0.000936	0.000936	CcSEcCtD
Hydrocodone—Paraesthesia—Methotrexate—systemic scleroderma	0.00093	0.00093	CcSEcCtD
Hydrocodone—Dyspnoea—Methotrexate—systemic scleroderma	0.000923	0.000923	CcSEcCtD
Hydrocodone—Somnolence—Methotrexate—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Hydrocodone—Hypersensitivity—Prednisone—systemic scleroderma	0.000913	0.000913	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Hydrocodone—Fatigue—Methotrexate—systemic scleroderma	0.000892	0.000892	CcSEcCtD
Hydrocodone—Asthenia—Prednisone—systemic scleroderma	0.000889	0.000889	CcSEcCtD
Hydrocodone—Pruritus—Prednisone—systemic scleroderma	0.000876	0.000876	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Hydrocodone—Dizziness—Prednisone—systemic scleroderma	0.000819	0.000819	CcSEcCtD
Hydrocodone—Abdominal pain—Methotrexate—systemic scleroderma	0.000818	0.000818	CcSEcCtD
Hydrocodone—Body temperature increased—Methotrexate—systemic scleroderma	0.000818	0.000818	CcSEcCtD
Hydrocodone—Vomiting—Prednisone—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Hydrocodone—Rash—Prednisone—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Hydrocodone—Dermatitis—Prednisone—systemic scleroderma	0.00078	0.00078	CcSEcCtD
Hydrocodone—Headache—Prednisone—systemic scleroderma	0.000776	0.000776	CcSEcCtD
Hydrocodone—Hypersensitivity—Methotrexate—systemic scleroderma	0.000763	0.000763	CcSEcCtD
Hydrocodone—Asthenia—Methotrexate—systemic scleroderma	0.000743	0.000743	CcSEcCtD
Hydrocodone—Nausea—Prednisone—systemic scleroderma	0.000736	0.000736	CcSEcCtD
Hydrocodone—Pruritus—Methotrexate—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Hydrocodone—Dizziness—Methotrexate—systemic scleroderma	0.000685	0.000685	CcSEcCtD
Hydrocodone—Vomiting—Methotrexate—systemic scleroderma	0.000658	0.000658	CcSEcCtD
Hydrocodone—Rash—Methotrexate—systemic scleroderma	0.000653	0.000653	CcSEcCtD
Hydrocodone—Dermatitis—Methotrexate—systemic scleroderma	0.000652	0.000652	CcSEcCtD
Hydrocodone—Headache—Methotrexate—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Hydrocodone—Nausea—Methotrexate—systemic scleroderma	0.000615	0.000615	CcSEcCtD
